Tibial muscular dystrophy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:609OMIM:600334G71.0
Who is this for?
Show terms as
3Active trials26Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Tibial muscular dystrophy (TMD), also known as Udd myopathy or Udd distal myopathy, is a rare inherited muscle disease that mainly affects the muscles at the front of the lower leg, particularly the tibialis anterior muscle. This is the muscle that helps you lift your foot upward when you walk. The disease causes these muscles to slowly weaken and waste away over time, which can make walking difficult and may eventually lead to a foot drop — a condition where you cannot lift the front part of your foot properly. TMD usually begins in adulthood, most often after the age of 35 to 40, and progresses very slowly. In most people, the weakness stays limited to the lower legs for many years or even decades. Some people may also develop mild weakness in other muscles over time, but the disease rarely affects the heart or breathing muscles significantly. There is currently no cure for tibial muscular dystrophy. Treatment focuses on managing symptoms and maintaining quality of life. Physical therapy, ankle-foot orthoses (special braces), and assistive devices can help people stay mobile and independent for a long time. Because the disease progresses slowly, many people live full and active lives with the right support.

Also known as:

Key symptoms:

Weakness in the muscles at the front of the lower legFoot drop — difficulty lifting the front of the foot when walkingTripping or stumbling more than usualDifficulty walking on heelsWasting or thinning of the lower leg musclesMild weakness in thigh muscles in some peopleDifficulty climbing stairs in later stagesSlow, gradual worsening of muscle strength over many yearsPossible mild weakness in other limb muscles over time

Clinical phenotype terms (19)— hover any for plain English
Steppage gaitHP:0003376Centrally nucleated skeletal muscle fibersHP:0003687Peroneal muscle atrophyHP:0009049Increased muscle lipid contentHP:0009058Ankle weaknessHP:0031374Quadriceps muscle weaknessHP:0003731Distal upper limb muscle weaknessHP:0008959Weakness of long finger extensor musclesHP:0009077
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Late onset

Begins later in life, typically after age 50

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Aug 2026Magnetic Ressonance Imaging of Temporomandibular Joint

Daniela Ap. Biasotto-Gonzalez — NA

TrialNOT YET RECRUITING
Jun 2026Effects of Vagus Nerve Stimulation on Temporomandibular Disorders.

Arpana Church — NA

TrialNOT YET RECRUITING
Jun 2026INNOVATIVE BENEFITS OF A 4D VIRTUAL SIMULATOR

Centre Hospitalier Universitaire de Nice — NA

TrialNOT YET RECRUITING
Apr 2026CBCT and Audiological Analysis of the TMJ-Tinnitus Relationship

Kutahya Health Sciences University

TrialNOT YET RECRUITING
Mar 2026Effectiveness of Photobiomodulation for Myofascial Pain in Temporomandibular Disorders

Federal University of Rio Grande do Sul — NA

TrialNOT YET RECRUITING
Mar 2026Clinical, Microbial and Tissue-based Characterization of Patients Treated for Severe Temporomandibular Joint Pathology

Örebro University, Sweden

TrialNOT YET RECRUITING
Mar 2026Psychosomatic Symptoms in Patients With Myofascial Pain and Temporomandibular Joint Dysfunction

Bahria University

TrialNOT YET RECRUITING
Feb 2026Morphometric and Morphological Analysis of Cervical Vertebrae in Disc Displacement

Kutahya Health Sciences University

TrialNOT YET RECRUITING
Feb 2026Occlusal Equilibration vs. Sham Therapies for TMDs: Post-Trial Follow-up (OEST)

Urbano Santana Penin

TrialRECRUITING
Feb 2026Virtual Planning of Total Temporomandibular Joint Replacement

Lund University Hospital

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Tibial muscular dystrophy.

3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

3 recruitingView all trials with filters →
N/A3 trials
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
N/A
Actively Recruiting
PI: Thomas C Bulea, Ph.D. (National Institutes of Health Clinical Center (CC)) · Sites: Bethesda, Maryland · Age: 317 yrs
Comparative Effects of Clamshell Technique With EMS vs CTin Iliotibial Band Tightness for Pain and Function
N/A
Active
· Sites: Lahore, Punjab Province · Age: 4565 yrs
Follow-up Study on Female Carriers With DMD Gene Variants
N/A
Enrolling by Invitation
· Sites: Copenhagen · Age: 1899 yrs

Specialists

Showing 25 of 26View all specialists →
CM
Craig McDonald, MD
Phoenix, Arizona
Specialist

Rare Disease Specialist

PI on 4 active trials
RD
Reza Tabrizi, DMD
Specialist
PI on 3 active trials
KA
Kacy Arnold
Specialist
PI on 2 active trials7 Tibial muscular dystrophy publications
VL
Victoria Lillback
Specialist
1 Tibial muscular dystrophy publication
AP
Aysenur TUNCER, PhD
Gaziantep, Hasan Kalyoncu University
Specialist

Rare Disease Specialist

PI on 4 active trials
MS
Marco Savarese
Specialist
1 Tibial muscular dystrophy publication
BU
Bjarne Udd
Specialist
1 Tibial muscular dystrophy publication
PH
Peter Hackman
Specialist
1 Tibial muscular dystrophy publication
NS
Niina Sandholm
Specialist
1 Tibial muscular dystrophy publication
TP
Thomas C Bulea, Ph.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 3 active trials
SM
Samrood Akram, Mphil
Specialist
PI on 2 active trials
SD
Sandra Donkervoort
Bethesda, Maryland
Specialist

Rare Disease Specialist

66 Tibial muscular dystrophy publications
MD
Maria G D'Angelo
Bosisio Parini, Lecco
Specialist

Rare Disease Specialist

12 Tibial muscular dystrophy publications
DG
Dr. Allan Gordon
Specialist
PI on 1 active trial
SL
Sarah A Elmaghraby, Lecturer
Specialist
PI on 1 active trial
AH
AbdElKader A Hyder
Specialist
PI on 2 active trials
ED
Edward S Kijak, DSc
Specialist
PI on 1 active trial
RB
Ramsis Magdy, BDS
Specialist
PI on 1 active trial
BR
Bilge Gokcen Rohlig
Specialist
PI on 1 active trial
MF
Manal foda
Specialist
PI on 1 active trial
GL
Gilles Lavigne
Specialist
PI on 1 active trial
SS
Simon von Stengel
Specialist
PI on 1 active trial
DD
Donald R Nixdorf, DDS
Specialist
PI on 1 active trial

Treatment Centers

8 centers
⚗️ Trial Site

National Institutes of Health Clinical Center

📍 Bethesda, Maryland

👤 Payal P Khincha, M.D.

👤 Christopher Grunseich, M.D.

⚗️ Trial Site

Children's Hospital Colorado

📍 Aurora, Colorado

👤 Zachary Grinspan, MD

⚗️ Trial Site

Arkansas Children's Hospital

📍 Little Rock, Arkansas

⚗️ Trial Site

Boston Children's Hospital

📍 Boston, Massachusetts

⚗️ Trial Site

Cincinnati Children's Hospital Medical Center

📍 Cincinnati, Ohio

⚗️ Trial Site

Ann & Robert H. Lurie Children's Hospital of Chicago

📍 Chicago, Illinois

⚗️ Trial Site

Phoenix Children's Hospital

📍 Phoenix, Arizona

👤 Study Director

⚗️ Trial Site

Akron Children's Hospital

📍 Akron, Ohio

👤 Study Director

Travel Grants

No travel grants are currently matched to Tibial muscular dystrophy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Tibial muscular dystrophyForum →

No community posts yet. Be the first to share your experience with Tibial muscular dystrophy.

Start the conversation →

Latest news about Tibial muscular dystrophy

Disease timeline:

New recruiting trial: Occlusal Equilibration vs. Sham Therapies for TMDs: Post-Trial Follow-up (OEST)

A new clinical trial is recruiting patients for Tibial muscular dystrophy

New recruiting trial: Treatment of Temporomandibular Disorders in Children and Adolsecents

A new clinical trial is recruiting patients for Tibial muscular dystrophy

New recruiting trial: Tele-Rehabilitation in Patients With Temporomandibular Dysfunction

A new clinical trial is recruiting patients for Tibial muscular dystrophy

New recruiting trial: Journaling Intervention for Temporomandibular Disorder (TMD) and Chronic Overlapping Pain

A new clinical trial is recruiting patients for Tibial muscular dystrophy

New recruiting trial: Impact of Orthodontic Treatment on the Temporomandibular Joints (TMJ) Assessed by Modjaw

A new clinical trial is recruiting patients for Tibial muscular dystrophy

New recruiting trial: Effects of Neck Stabilizers Retraining on Chronic Neck Pain

A new clinical trial is recruiting patients for Tibial muscular dystrophy

New recruiting trial: Comparison of Treatment Modalities in Myofascial Pain Syndrome

A new clinical trial is recruiting patients for Tibial muscular dystrophy

New recruiting trial: Virtual Planning of Total Temporomandibular Joint Replacement

A new clinical trial is recruiting patients for Tibial muscular dystrophy

New recruiting trial: The New Serial Treatment of Temporomandibular Disorders

A new clinical trial is recruiting patients for Tibial muscular dystrophy

New recruiting trial: TMJ Arthroscopy Compared to Arthrocentesis in Disc Displacement Without Reduction

A new clinical trial is recruiting patients for Tibial muscular dystrophy

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific TTN gene mutation do I have, and what does that mean for how my disease might progress?,Should my family members be tested for this condition, and if so, who should be tested first?,Would an ankle-foot orthosis (brace) help me, and how do I get fitted for one?,How often should I have follow-up appointments, and what tests will be done to monitor my condition?,Are there any clinical trials or research studies I could participate in?,What type of exercise is safe and beneficial for me, and should I avoid any activities?,Are there any other muscles or organs I should be monitored for, such as the heart?

Common questions about Tibial muscular dystrophy

What is Tibial muscular dystrophy?

Tibial muscular dystrophy (TMD), also known as Udd myopathy or Udd distal myopathy, is a rare inherited muscle disease that mainly affects the muscles at the front of the lower leg, particularly the tibialis anterior muscle. This is the muscle that helps you lift your foot upward when you walk. The disease causes these muscles to slowly weaken and waste away over time, which can make walking difficult and may eventually lead to a foot drop — a condition where you cannot lift the front part of your foot properly. TMD usually begins in adulthood, most often after the age of 35 to 40, and progre

How is Tibial muscular dystrophy inherited?

Tibial muscular dystrophy follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Tibial muscular dystrophy typically begin?

Typical onset of Tibial muscular dystrophy is late onset. Age of onset can vary across affected individuals.

Are there clinical trials for Tibial muscular dystrophy?

Yes — 3 recruiting clinical trials are currently listed for Tibial muscular dystrophy on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Tibial muscular dystrophy?

25 specialists and care centers treating Tibial muscular dystrophy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.